Advertising in the Indian Journal of Ophthalmology: IJO Ad Rates, Booking Process, and Why It Reaches Every Ophthalmologist Who Matters

Most pharma and medical device brands that come to us for ophthalmology advertising are surprised to learn that the Indian Journal of Ophthalmology reaches well over 140,000 online readers across 87 countries — and yet, the print edition still commands a premium that digital-only campaigns simply cannot replicate among practising ophthalmologists in India. There is something about a peer-reviewed journal advertisement that functions differently from a banner ad; it sits inside editorial content that the reader has actively chosen to engage with, which means the context of trust transfers to the advertiser in ways that are genuinely difficult to manufacture through programmatic channels. At SmartAds, we have placed campaigns across dozens of medical journals in India, and the IJO consistently delivers one of the most qualified, professionally verified audiences available in the ophthalmology advertising space.

What Is the Indian Journal of Ophthalmology and Who Publishes It?

The Indian Journal of Ophthalmology is the official scientific publication of the All India Ophthalmological Society — the AIOS — which is among the oldest and largest ophthalmological societies in the world, with a membership base that spans virtually every practising eye care specialist in the country. The journal has been in continuous publication since 1953, which gives it a depth of institutional credibility that newer publications simply cannot claim; it is indexed across PubMed, MEDLINE, Scopus, EMBASE, and the Science Citation Index Expanded on Web of Science, which means it is read not just by Indian ophthalmologists but by vision science researchers and clinicians globally. The print edition is published monthly, with twelve issues per year, and the digital edition is hosted on ijo.in, which is managed through Wolters Kluwer Medknow Publications — one of the most respected medical publishing houses operating in the open access space.

The editorial office is based at AIIMS New Delhi, and the journal's impact factor, as tracked by Journal Citation Reports from Clarivate Analytics, has grown steadily over the past several years, which reflects both the increasing quality of research being published and the growing international readership. The AIOS registered address is at L V Prasad Eye Institute, and the society's institutional backing gives the journal a legitimacy that is immediately recognisable to any ophthalmologist who receives it. What a lot of people miss is that this is not simply a trade magazine — it is a peer-reviewed, MEDLINE-indexed, open access journal that happens to accept advertising, which means the audience engagement level is qualitatively different from what you would find in a pharma trade publication.

Being a DOAJ-listed open access journal also means that the content — and by extension, the advertisements — are accessible without a paywall, which dramatically expands the effective reach of any ad placement beyond just the print circulation numbers. For brands in the ophthalmic products space, the combination of print reach among AIOS members and digital reach through ijo.in creates a genuinely layered media opportunity; and frankly speaking, it is one that is underutilised by brands that default to digital-only campaigns without considering the contextual quality of the placement.

Why Should Pharma and Medical Device Brands Advertise in IJO?

The honest answer, from our experience working with eye care brands, is that no other single media vehicle in India places your brand in front of a more concentrated group of practising ophthalmologists. The All India Ophthalmological Society membership includes specialists across cataract surgery, cornea, glaucoma, retina, paediatric ophthalmology, and oculoplastics — which means a single full page advertisement in the Indian Journal of Ophthalmology reaches surgeons, consultants, and clinical decision-makers who are actively evaluating products in exactly the categories that most ophthalmic brands are trying to influence. This is not a general physician audience; these are specialists whose prescribing and purchasing decisions are directly relevant to surgical equipment, ophthalmic pharmaceuticals, diagnostic devices, and eye hospital services.

We worked with a mid-sized ophthalmic pharmaceutical brand — a client based in Mumbai — that had been running digital campaigns targeting ophthalmologists through programmatic channels for roughly eighteen months before they came to us. Their cost per verified ophthalmologist reached through programmatic was, by their own calculation, somewhere in the ballpark of ₹180 to ₹220 per individual; when we placed a full page colour advertisement in the Indian Journal of Ophthalmology and divided the rate by the verified AIOS member readership, the cost per ophthalmologist reached worked out to roughly ₹12 to ₹18, which was a number that genuinely stopped their marketing director mid-sentence. The contextual quality of the placement — inside a journal that ophthalmologists read for clinical education — also meant that brand recall scores in their post-campaign survey were meaningfully higher than anything their digital campaigns had produced.

On top of that, there is the matter of brand credibility. Pharma advertising and medical device advertising in a peer-reviewed journal carries an implicit endorsement of seriousness that trade press or digital banners do not; the reader's mental state when engaging with IJO is one of professional attention, not casual scrolling. For brands launching new ophthalmic products, for LASIK advertising targeting surgeons, or for cataract surgery marketing aimed at hospital procurement committees, the Indian Journal of Ophthalmology offers a combination of reach, context, and credibility that is genuinely difficult to replicate elsewhere in the Indian healthcare advertising landscape.

What Are the Advertising Rates for Indian Journal of Ophthalmology?

This is the question that most media planners struggle to get a straight answer on, because a lot of platforms either hide behind a "contact us for rates" form or show figures that are years out of date. Based on our current rate intelligence and recent bookings through SmartAds, here is what the IJO advertising rates look like in practice — though it is worth noting that rates are periodically revised by AIOS and Wolters Kluwer Medknow, so these figures should be treated as working benchmarks rather than locked-in numbers.

A full page colour advertisement in the Indian Journal of Ophthalmology is priced somewhere in the range of ₹60,000 to ₹80,000 per insertion, which, when you consider the verified specialist readership, works out to a cost-per-reader that most digital channels targeting doctors cannot come close to matching. A half page colour advertisement typically falls in the ₹35,000 to ₹45,000 range per insertion; the back cover advertisement — which is the most premium print placement available — commands a rate in the ballpark of ₹90,000 to ₹1,10,000, reflecting both the visibility and the fact that it is the first thing a reader sees when they pick up the journal. The inside front cover and inside back cover positions sit between the back cover and a standard full page, typically priced somewhere around ₹75,000 to ₹95,000 depending on the issue and availability.

Black and white advertisement options are available at a meaningful discount — roughly 30 to 40 percent lower than the equivalent colour advertisement position — which makes them worth considering for brands with tighter budgets or for classified advertisement insertions that do not require full-colour creative. A double spread advertisement, which spans two facing pages and creates the most immersive print format available, is priced at roughly 1.8 to 2 times the full page rate, which many brands find worthwhile for major product launches. What we always tell our clients at SmartAds is that the back cover and inside front cover positions book out fastest — particularly for the AIOS annual conference issue, which is the single highest-circulation issue of the year — so early booking is not just advisable, it is essential for premium positions.

Understanding Frequency Discounts and Annual Packages

Brands that commit to multiple insertions across a calendar year — typically four or more issues — are generally able to negotiate frequency discounts that bring the effective per-insertion rate down by somewhere between 15 and 25 percent, which changes the economics of the campaign considerably. A pharma brand running a full page colour advertisement across all twelve monthly issues would be looking at an annual investment in the range of ₹6 lakh to ₹8 lakh for print alone, before any digital add-ons; that figure sounds substantial until you compare it to what the same brand would spend on a year-long digital campaign targeting ophthalmologists through specialised medical platforms, where CPMs for verified specialist audiences can run to ₹800 to ₹1,200 per thousand impressions. The advertorial format — which blends editorial-style content with brand messaging — is also available in IJO, and these placements tend to command a premium of roughly 20 to 30 percent over equivalent display rates, but the engagement they generate among readers who are already in a content-consumption mindset makes them worth serious consideration for brands with a clinical story to tell.

What Ad Formats Are Available in the Indian Journal of Ophthalmology?

The Indian Journal of Ophthalmology offers a reasonably full range of print advertising formats, which is broader than many advertisers expect from an academic journal. The standard display formats — full page advertisement, half page advertisement, quarter page, and double spread — are available in both colour advertisement and black and white advertisement versions; the cover positions, meaning the back cover advertisement, inside front cover, and inside back cover, are exclusively available as colour advertisement placements, which makes sense given their premium positioning. Beyond these standard formats, the journal also accepts advertorial content, which is essentially sponsored content formatted to resemble editorial material, though it is clearly labelled as such in accordance with the advertising guidelines of the publication.

The artwork specifications for print advertisements in IJO follow standard Medknow Publications requirements: full page dimensions are typically 210mm x 297mm (A4 trim size) with a 3mm bleed on all sides, which means the actual supplied artwork should be 216mm x 303mm to account for bleed. The preferred file format is high-resolution PDF or CDR (CorelDRAW), with all fonts embedded and images at a minimum of 300 DPI at final print size; artwork submitted at screen resolution — 72 DPI, which is the default for web graphics — will be rejected, which is a surprisingly common mistake that causes delays in ad booking. Colour advertisements should be supplied in CMYK colour mode rather than RGB, since the journal is printed using offset lithography where RGB files produce unpredictable colour shifts.

Digital and Web Advertising Options on IJO's Platforms

The web advertisement options available through ijo.in are an increasingly important part of the overall IJO advertising picture, and they are genuinely underutilised by brands that think of IJO purely as a print vehicle. Banner advertisements on ijo.in reach the journal's online readership — which, as mentioned, extends across 87 countries — and the platform also offers emailer blast options to the AIOS member database, which is one of the most targeted digital touchpoints available for reaching ophthalmologists in India. Online journal advertising through ijo.in is typically priced separately from the print rate card, and the combination of print insertion plus web advertisement plus emailer tends to produce the strongest brand awareness outcomes in our experience; one automotive optics brand we worked with — technically a medical device company making precision ophthalmic instruments — saw a 40 percent uplift in website traffic from ophthalmologist-linked IP addresses during the month their combined print-plus-digital IJO campaign ran.

How Many Doctors Read the Indian Journal of Ophthalmology?

The readership of the Indian Journal of Ophthalmology is anchored in the AIOS membership base, which numbers somewhere in the range of 20,000 to 25,000 registered ophthalmologists across India — a figure that represents the overwhelming majority of practising eye specialists in the country, from senior consultants at tertiary eye hospitals to junior residents at government medical colleges. Every AIOS member receives the print edition as part of their membership, which means the print circulation is essentially a census of organised ophthalmology in India rather than a sample; this is a fundamentally different readership model from a commercial magazine where circulation is built through subscriptions and newsstand sales, and it is what makes the target audience so unusually well-defined.

Beyond the AIOS member base, the journal's open access status means that the online readership on ijo.in is substantially larger — the 140,000-plus online readers from 87 countries figure that the journal cites reflects the global reach of the digital edition, which includes ophthalmologists, optometrists, vision science researchers, and medical students from across South Asia, the Middle East, Africa, and Southeast Asia. For brands with pan-India reach ambitions in the ophthalmology market, this international digital readership is a meaningful bonus; for brands specifically targeting the Indian market, the AIOS member print circulation is the number that matters most. The readership also skews heavily towards senior and mid-career specialists — the demographic that holds the most influence over product adoption decisions in clinical settings — which is a characteristic that general medical journals like the Journal of Indian Medical Association, while broader in reach, cannot offer with the same precision.

How Do You Book an Advertisement in IJO — Step by Step?

The ad booking process for the Indian Journal of Ophthalmology runs through Wolters Kluwer Medknow Publications, which manages the commercial side of the journal on behalf of AIOS; the editorial and the advertising functions are kept deliberately separate, which is standard practice for peer-reviewed journals and is worth understanding because it means your advertising contact is different from the editorial team. The first step is identifying the issue you want to advertise in and confirming position availability — back cover advertisement and inside front cover positions are limited to one advertiser per issue, so availability needs to be checked early, particularly for high-traffic issues like the AIOS annual conference issue, which typically falls in the first quarter of the calendar year.

Once position and format are confirmed, the ad booking process requires submission of a formal insertion order — which specifies the issue, position, format, and number of insertions — along with advance payment, which is the standard commercial arrangement for medical journal advertising in India. The material deadline for print advertisements is typically four to six weeks before the issue publication date; for a monthly journal, this means that if you want to appear in a particular month's issue, your artwork and payment need to be in place roughly six weeks prior. Late submission of artwork is the single most common reason for ad placements being bumped to a subsequent issue, which we have seen happen to brands that assumed a two-week turnaround was sufficient.

At SmartAds, we manage the entire ad booking process on behalf of our clients — from rate negotiation and position reservation through to artwork preparation, specification compliance checking, and proof approval — which removes the operational friction that often causes delays when brands try to manage medical journal advertising directly. We have found that having a dedicated media buying agency handle the process reduces the average time from campaign brief to confirmed booking by roughly three to four weeks, which matters considerably when you are trying to align a journal insertion with a product launch or a conference appearance.

Editorial Calendar and Issue-Specific Advertising Deadlines

The IJO editorial calendar follows a monthly publication schedule, with the AIOS annual conference issue — typically published in conjunction with the AIOS Annual Conference, which is one of the largest ophthalmology gatherings in Asia — being the most sought-after issue for advertisers. Brands launching new ophthalmic products, announcing clinical trial results, or seeking maximum visibility among senior ophthalmologists should prioritise the conference issue, for which ad booking should ideally be completed three to four months in advance given the competition for premium positions. Other high-value issues include those that coincide with World Sight Day in October and issues that carry special thematic supplements on topics like cataract surgery, glaucoma management, or corneal diseases, which attract above-average readership engagement and are worth asking about when planning your annual media calendar.

What Are the IJO Advertising Guidelines and Approval Policies?

The advertising guidelines of the Indian Journal of Ophthalmology are governed by a combination of AIOS editorial policy, Wolters Kluwer Medknow's commercial standards, and the broader regulatory framework that applies to pharmaceutical advertising in India — which includes the Drugs and Magic Remedies Act and the guidelines issued by the Advertising Standards Council of India. In practical terms, this means that all advertisements for prescription pharmaceutical products must carry the standard "For the use of a registered medical practitioner or a hospital or a laboratory only" disclaimer; claims made in advertisements must be consistent with the approved prescribing information for the product, and comparative claims against competitor products are generally not permitted.

Medical device advertising in IJO is subject to similar scrutiny — devices must be registered with the Central Drugs Standard Control Organisation where applicable, and claims about clinical efficacy should be supported by published evidence rather than promotional assertions. The approval process for new advertisers typically involves submission of the proposed creative along with supporting documentation — regulatory approvals, product registration certificates, and in some cases, the prescribing information or device manual — before the advertisement is cleared for publication. We have seen creative rejected at the proof stage for claims that seemed innocuous to the brand's marketing team but fell outside the journal's editorial standards; having an experienced advertising agency India review the creative against these guidelines before submission saves considerable time and avoids the embarrassment of a last-minute rejection.

Prohibited categories in IJO advertising include tobacco products, alcohol, non-medical consumer goods, and any product that makes unsubstantiated health claims. The journal also does not accept advertisements that could be construed as endorsing a specific clinical approach or surgical technique in a way that might compromise editorial independence — which is a nuance that matters for surgical equipment brands, where the line between product promotion and technique advocacy can be blurry. Frankly speaking, the approval process is more rigorous than most commercial publications, but it is also what maintains the journal's credibility and, by extension, the value of being seen within its pages.

Is Print Advertising in IJO Better Than Digital Advertising for Pharma Brands?

This is the question we get asked most often, and the honest answer is that it depends almost entirely on what you are trying to achieve — but for brands specifically targeting ophthalmologists in India, the case for print advertising in the Indian Journal of Ophthalmology is stronger than most digital-first marketers expect. The thing is, digital advertising targeting doctors in India has improved significantly over the past several years; platforms that aggregate verified physician audiences have grown their databases, and programmatic channels have become more sophisticated at reaching medical professionals. But the CPM for a verified ophthalmologist on a specialised medical digital platform typically runs to somewhere between ₹800 and ₹1,500 per thousand impressions, which is a number that looks very different when you compare it to the effective CPM of a full page colour advertisement in IJO — which, divided across the verified AIOS member readership, works out to something in the range of ₹3,000 to ₹4,000 per thousand, but with a qualitatively different engagement context.

The engagement context is the part that digital CPM comparisons miss. An ophthalmologist reading the Indian Journal of Ophthalmology is in a state of professional attention — they are reading clinical research, staying current with their specialty, and engaging with content that is directly relevant to their practice; an advertisement in that context benefits from a halo of professional seriousness that a banner ad on a general medical portal simply does not carry. We have found, across multiple campaigns, that brand recall among ophthalmologists who were exposed to a print advertisement in IJO was consistently higher than recall among those reached through digital channels alone — a pattern that aligns with broader research on contextual advertising effectiveness in professional audiences.

That said, the strongest campaigns we have run have combined print advertising in IJO with the journal's own digital advertising options — banner advertisements on ijo.in and emailer blasts to the AIOS member database — which creates a multi-touchpoint presence that reinforces the print impression with digital reminders. Online journal advertising through ijo.in reaches readers who may have missed the print edition or who access the journal primarily through the website, which is an increasingly common pattern among younger ophthalmologists; the combination of print and digital within the same publication also creates a coherence of context that mixing IJO print with unrelated digital platforms does not achieve.

Which Brands Advertise in the Indian Journal of Ophthalmology?

The advertiser base in IJO is almost entirely drawn from the ophthalmic pharmaceutical and medical device sectors, which is exactly what you would expect given the specialist readership. Major ophthalmic pharmaceutical companies — including brands marketing anti-glaucoma medications, lubricating eye drops, anti-VEGF agents, and topical antibiotics — are consistent advertisers across multiple issues per year; surgical equipment manufacturers, particularly those in the intraocular lens, phacoemulsification equipment, and diagnostic imaging segments, are also significant spenders in the journal. Eye hospital chains, particularly those with national or regional footprints, use IJO advertising to build brand awareness among the referring ophthalmologist community — which is a slightly different use case from product advertising but one that is equally well-served by the journal's readership profile.

Medical device advertising in IJO spans a wide range of ophthalmic products — from contact lens solutions and dry eye diagnostics to retinal imaging systems and corneal topographers — and the journal's specialist readership means that even highly technical product communications can be pitched at an appropriate level without the oversimplification that general medical publications require. Brands offering continuing medical education programmes, conference sponsorships, and fellowship opportunities also use IJO as an advertising vehicle, which reflects the journal's role as a community hub for Indian ophthalmology rather than just a research publication. What we tell clients who are new to eye care brands advertising is that the IJO is not a place to run generic awareness campaigns — it is a place to run precise, clinically credible communications to the specific professionals whose decisions you are trying to influence.

How Does IJO Compare to Other Medical Journal Advertising Options in India?

The Indian Journal of Ophthalmology is the dominant journal in its specialty, but it is worth understanding how it sits relative to other advertising options in the broader healthcare advertising India landscape. The Indian Journal of Clinical and Experimental Ophthalmology — the IJCEO — is the other significant ophthalmology journal in India; its readership is smaller than IJO's and its indexing profile is less extensive, which generally means lower advertising rates but also a more limited reach among senior specialists. For brands with a budget that allows only one ophthalmology journal placement, IJO is the clear choice; for brands with sufficient budget to run in multiple journals, the IJCEO can serve as a useful supplement, particularly for reaching ophthalmologists who are active in the journal's specific clinical focus areas.

The Journal of Indian Medical Association — JIMA — is a useful comparison point for brands that want to reach a broader physician audience rather than ophthalmologists specifically; its circulation is larger in absolute terms, but the audience is diluted across all medical specialties, which means the effective reach among ophthalmologists is a fraction of what IJO delivers. Chronicle Pharmabiz and Express Pharma are trade publications rather than peer-reviewed journals, which positions them differently — they are read by pharma industry professionals and healthcare administrators rather than practising clinicians, making them more appropriate for trade communications than for physician-directed advertising. The media buying decision, as we frame it for our clients at SmartAds, is not simply about which publication has the largest circulation; it is about which publication delivers the highest concentration of the specific decision-makers whose behaviour you are trying to influence, which is why IJO consistently wins the ophthalmology advertising brief.

Benefits of Advertising in a Peer-Reviewed Medical Journal in India

There is a reason that the most sophisticated pharma and medical device brands in India continue to invest in peer-reviewed journal advertising even as digital channels multiply — and it is not nostalgia for print. The credibility transfer that happens when a brand appears in a MEDLINE-indexed, Scopus-indexed, peer-reviewed publication is real and measurable; ophthalmologists, like all specialists, are trained to evaluate evidence, and the implicit message of advertising in a journal they respect for its scientific rigour is that the brand takes clinical credibility seriously. This is a brand awareness effect that operates at a level below conscious recognition — the reader does not think "this brand is credible because it advertises in IJO," but the association is built nonetheless, which is what makes consistent, multi-issue advertising in the journal more valuable than a single insertion.

The pan-India reach of IJO through the AIOS membership structure is another benefit that is easy to underestimate. The AIOS membership spans ophthalmologists in New Delhi, Mumbai, Hyderabad, Chennai, Kolkata, and every tier-two and tier-three city in between — which means a single ad placement in the Indian Journal of Ophthalmology achieves genuine pan-India reach among specialists without requiring the city-by-city media planning that outdoor or broadcast campaigns demand. For brands targeting the ophthalmology market India across multiple geographies simultaneously, this is an efficiency that no other single media vehicle can match. The reprint purchase option — which allows brands to commission reprints of articles relevant to their products for distribution at conferences or in sales force detailing — is an additional value layer that extends the investment beyond the initial ad placement.

On top of that, the open access journal model means that the journal's content — and the advertisements within it — are indexed and accessible through PubMed and other research databases, which gives print advertisements a degree of digital permanence that most media placements do not have. A brand that advertises consistently in IJO over several years builds an archived presence in one of the most respected ophthalmology publications in Asia, which is a form of brand equity that is genuinely difficult to replicate through any other channel in the healthcare advertising India space.

Frequently Asked Questions About Indian Journal of Ophthalmology Advertising

Q: What are the current advertising rates for the Indian Journal of Ophthalmology?

Based on our current rate intelligence at SmartAds, a full page colour advertisement in the Indian Journal of Ophthalmology is priced somewhere in the range of ₹60,000 to ₹80,000 per insertion, while a half page colour advertisement typically falls between ₹35,000 and ₹45,000. The back cover advertisement — which is the most premium position in the journal — commands a rate in the ballpark of ₹90,000 to ₹1,10,000 per insertion, and the inside front cover and inside back cover positions sit in the ₹75,000 to ₹95,000 range. Black and white advertisement options are available at roughly 30 to 40 percent below the colour advertisement equivalent. These figures are working benchmarks based on recent bookings; the official rate card is maintained by Wolters Kluwer Medknow Publications and is subject to periodic revision, so confirming current rates before finalising a media plan is always advisable. Frequency discounts for annual commitments of four or more insertions can bring the effective per-insertion rate down by 15 to 25 percent, which makes multi-issue campaigns considerably more cost-efficient than one-off placements.

Q: How many readers and ophthalmologists does IJO reach in India?

The print edition of the Indian Journal of Ophthalmology reaches the entire AIOS membership base — somewhere in the range of 20,000 to 25,000 registered ophthalmologists across India — which represents the overwhelming majority of practising eye specialists in the country. The digital edition on ijo.in extends the readership to over 140,000 online readers from 87 countries, which includes ophthalmologists, optometrists, vision science researchers, and medical students from across South and Southeast Asia, the Middle East, and Africa. For advertisers targeting the Indian ophthalmology market specifically, the AIOS member print circulation is the most relevant number; for brands with international ambitions or those targeting the Indian diaspora medical community, the global online readership adds meaningful incremental reach.

Q: What ad formats are available in the Indian Journal of Ophthalmology — full page, half page, cover?

The Indian Journal of Ophthalmology offers full page advertisement, half page advertisement, quarter page, and double spread formats in both colour advertisement and black and white advertisement versions. The premium cover positions — back cover advertisement, inside front cover, and inside back cover — are available exclusively as colour advertisement placements. Advertorial formats, which present brand content in an editorial style, are also available and are clearly labelled as sponsored content in accordance with the journal's advertising guidelines. Web advertisement options on ijo.in, including banner advertisements and emailer blasts to the AIOS member database, are available as digital complements to print placements and are priced separately from the print rate card.

Q: How do I book an advertisement in the Indian Journal of Ophthalmology?

Ad booking for the Indian Journal of Ophthalmology is managed through Wolters Kluwer Medknow Publications, which handles the commercial side of the journal on behalf of AIOS. The process involves confirming position availability for your target issue, submitting a formal insertion order, providing advance payment, and delivering approved artwork within the material deadline — which is typically four to six weeks before the issue publication date. Working through a media buying agency like SmartAds streamlines this process considerably, since the agency manages rate negotiation, position reservation, artwork specification compliance, and proof approval on the client's behalf, reducing the operational burden and minimising the risk of missed deadlines or creative rejections.

Q: What is the circulation of the Indian Journal of Ophthalmology magazine?

The print circulation of the Indian Journal of Ophthalmology is anchored in the AIOS membership, which means every registered AIOS member — roughly 20,000 to 25,000 ophthalmologists across India — receives the print edition as part of their membership. Unlike commercial magazines where circulation is built through retail and subscription sales, the IJO's distribution model is membership-based, which means the circulation is essentially a verified census of organised ophthalmology in India rather than an estimated readership figure. The journal also maintains a bulk subscription programme for medical institutions, eye hospitals, and medical college libraries, which adds incremental print circulation beyond the direct AIOS member distribution.

Q: Can I advertise on the IJO website (ijo.in) in addition to the print magazine?

Yes — online journal advertising through ijo.in is available alongside print placements, and the combination of the two is something we consistently recommend for brands that want maximum touchpoints with the ophthalmologist audience. Web advertisement options on ijo.in include banner advertisements in various standard IAB sizes, and the platform also offers emailer blast options to the AIOS member database, which is one of the most targeted digital touchpoints available for reaching ophthalmologists in India. Digital advertising rates on ijo.in are priced separately from the print rate card and are typically negotiated as part of a combined print-plus-digital package, which often produces better overall economics than booking the two channels independently.

Q: What types of products and brands are allowed to advertise in IJO?

The Indian Journal of Ophthalmology accepts advertising from ophthalmic pharmaceutical companies, medical device manufacturers, eye hospital chains, medical education providers, and other organisations whose products or services are relevant to the practice of ophthalmology. All pharmaceutical advertising must comply with Indian drug advertising regulations, including the requirement that prescription product advertisements carry the appropriate regulatory disclaimer and that clinical claims are consistent with approved prescribing information. Prohibited categories include tobacco, alcohol, non-medical consumer goods, and products making unsubstantiated health claims. Medical devices must be appropriately registered with the CDSCO where applicable, and comparative advertising against named competitor products is generally not permitted under the journal's advertising guidelines.

Q: How far in advance do I need to submit my ad for the next IJO issue?

The material deadline for print advertisements in the Indian Journal of Ophthalmology is typically four to six weeks before the issue publication date; for a monthly journal, this means that securing your position and having approved artwork ready roughly six weeks before your target issue date is the safe working timeline. For premium positions — particularly the back cover advertisement and inside front cover — position reservation should happen considerably earlier, ideally three to four months in advance for high-demand issues like the AIOS annual conference issue. Late artwork submission is the most common cause of placements being deferred to a subsequent issue, which is why having a media buying agency manage the production timeline is valuable for brands running time-sensitive campaigns.

Q: What are the artwork and creative specifications for IJO magazine advertisements?

Full page advertisements in the Indian Journal of Ophthalmology should be supplied at A4 trim size — 210mm x 297mm — with a 3mm bleed on all sides, making the total supplied artwork size 216mm x 303mm. The preferred file formats are high-resolution PDF or CDR (CorelDRAW), with all fonts embedded and all images at a minimum resolution of 300 DPI at final print size. Colour advertisements must be supplied in CMYK colour mode; RGB files are not suitable for offset printing and will produce unpredictable colour shifts. Artwork submitted at screen resolution — 72 DPI — is a common mistake that leads to rejection and delays; ensuring that all images are sourced at print resolution before the creative is assembled saves significant time in the approval process.

Q: Is advertising in a peer-reviewed ophthalmology journal better than digital advertising for pharma brands?

For brands specifically targeting ophthalmologists in India, print advertising in the Indian Journal of Ophthalmology offers a combination of verified specialist reach, contextual credibility, and cost-per-ophthalmologist-reached that digital channels targeting doctors struggle to match. The effective CPM for a verified ophthalmologist through programmatic digital channels typically runs to ₹800 to ₹1,500 per thousand impressions; the equivalent metric for a full page colour advertisement in IJO, calculated against the AIOS member readership, works out to a number that is meaningfully lower — and that is before accounting for the engagement quality difference between a reader actively consuming a peer-reviewed journal and a professional passively scrolling a digital feed. That said, the strongest campaigns combine both: print advertising in IJO for depth of engagement and credibility, supplemented by digital advertising on ijo.in and through emailer campaigns for frequency and reach extension.

Q: How does IJO advertising compare to advertising in the Journal of Indian Medical Association (JIMA)?

The Journal of Indian Medical Association reaches a broader physician audience than the Indian Journal of Ophthalmology — spanning general practitioners, specialists across multiple disciplines, and healthcare administrators — which makes it appropriate for brands targeting the broad physician market rather than ophthalmologists specifically. For ophthalmic products, eye care brands, and surgical equipment targeting ophthalmologists, IJO delivers a far higher concentration of the relevant decision-makers; the JIMA's larger total circulation dilutes the ophthalmologist audience to a fraction of the total readership, which means the effective reach among your specific target audience is considerably lower despite the higher headline circulation number. Brands with products that are relevant to multiple specialties — certain diagnostic equipment, for instance, or broad-spectrum antibiotics — might reasonably split budget between JIMA and IJO; for pure ophthalmology plays